Envista Holdings Corporation (NVST) experienced a significant post-market surge of 12.59%, following the release of its fourth-quarter and full-year 2025 financial results.
The dental products leader reported quarterly sales of $750.6 million, surpassing the analyst consensus estimate of $680 million. Adjusted earnings per share came in at $0.38, beating the expected $0.32. The results were driven by a 10.8% increase in core sales growth and a 22% rise in adjusted EBITDA, with positive performance noted across all major business segments and geographies.
Investor sentiment was further bolstered by the company's 2026 guidance, which projects core sales growth between 2% and 4% and forecasts adjusted earnings per share in the range of $1.35 to $1.45. The company also highlighted it returned $166 million to shareholders through share repurchases in 2025.